Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-51,100
Closed -$3.45M 6592
2025
Q3
$3.45M Buy
+51,100
New +$3.39M ﹤0.01% 3993
2018
Q1
Sell
-21,000
Closed -$898K 6094
2017
Q4
$898K Buy
21,000
+5,400
+35% +$215K ﹤0.01% 4405
2017
Q3
$572K Buy
15,600
+14,300
+1,100% +$577K ﹤0.01% 5003
2017
Q2
$59K Sell
1,300
-37,800
-97% -$1.67M ﹤0.01% 6318
2017
Q1
$1.66M Buy
39,100
+1,000
+3% +$40.8K ﹤0.01% 3934
2016
Q4
$1.53M Buy
38,100
+27,600
+263% +$1.07M ﹤0.01% 4095
2016
Q3
$407K Buy
10,500
+5,300
+102% +$200K ﹤0.01% 5228
2016
Q2
$180K Sell
5,200
-2,700
-34% -$93.5K ﹤0.01% 5776
2016
Q1
$273K Sell
7,900
-78,700
-91% -$2.74M ﹤0.01% 5350
2015
Q4
$3.35M Sell
86,600
-91,700
-51% -$3.57M ﹤0.01% 3186
2015
Q3
$6.98M Buy
178,300
+111,700
+168% +$4.43M ﹤0.01% 2574
2015
Q2
$2.54M Sell
66,600
-148,100
-69% -$5.18M ﹤0.01% 3598
2015
Q1
$7.09M Buy
214,700
+177,900
+483% +$5.46M ﹤0.01% 2578
2014
Q4
$984K Buy
36,800
+16,500
+81% +$426K ﹤0.01% 4577
2014
Q3
$494K Sell
20,300
-483,000
-96% -$12.2M ﹤0.01% 5277
2014
Q2
$12.8M Buy
503,300
+336,000
+201% +$7.85M ﹤0.01% 2176
2014
Q1
$3.6M Buy
167,300
+61,600
+58% +$1.33M ﹤0.01% 3404
2013
Q4
$2.36M Sell
105,700
-499,800
-83% -$11M ﹤0.01% 3905
2013
Q3
$12.5M Buy
605,500
+429,700
+244% +$9.15M ﹤0.01% 2022
2013
Q2
$3.39M Buy
+175,800
New +$3.67M ﹤0.01% 3147

Other funds holding HOLX

Goldman Sachs's HOLX Position: Q1 2026 in Review

Goldman Sachs increased its Hologic (HOLX) stake by 131% in Q1 2026, buying an estimated $99M and bringing the position to 2,322,673 shares worth $176M. The position accounts for 0.02% of the portfolio, ranked #731.

Goldman Sachs first reported a position in HOLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $253M in Q1 2021. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Goldman Sachs held 2,322,673 shares of Hologic worth $176M as of Q1 2026.
  • Goldman Sachs bought 1,316,484 Hologic shares in Q1 2026, an estimated $99M.
  • Hologic made up 0.02% of Goldman Sachs's portfolio in Q1 2026, its #731 holding.
  • Goldman Sachs first reported a position in Hologic in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Hologic position peaked at $253M in Q1 2021.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.